English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Thursday, January 11, 2024
富士通、小売業界で世界最大規模の展示会「NRF 2024」に出展
Fujitsu highlights unified and sustainable shopper journeys at retail's big show, NRF 2024
Wednesday, January 10, 2024
Fujitsu prepares for disclosure in line with TNFD framework, registers as TNFD Adopter
富士通、TNFDフレームワークに沿った情報開示を宣言
Tuesday, December 26, 2023
Fujitsu to launch dedicated company for hardware business in Japan
Monday, May 22, 2023
Tokyo Tech, Tohoku University, Fujitsu, and RIKEN start collaboration to develop distributed training of Large Language Models
Thursday, May 18, 2023
Fujitsu launches Biodrug Design Accelerator platform to accelerate peptide drug discovery research
富士通、ペプチド創薬の研究プロセスを管理するプラットフォーム「Biodrug Design Accelerator」を提供開始
Wednesday, May 17, 2023
京都大学・Chordia Therapeutics・富士通、因果関係を発見するAI技術を用いてがんの新薬に対するバイオマーカーを発見する実証実験を開始
Fujitsu, Kyoto University, and Chordia Therapeutics launch AI trials to discover biomarkers for new cancer drugs
Fujitsu Ltd Links

https://plus.google.com/+Fujitsu

https://www.facebook.com/FujitsuJapan

https://twitter.com/Fujitsu_Global

https://www.youtube.com/user/FujitsuOfficial

https://www.linkedin.com/company/fujitsu/

Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575